Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-324446 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 30, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
49,884
Total Value
$609,635.55
P&L
+inf% (+$1,058,627.81)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jul 28, 2026 | Grant/Award | 31,667 | $0.00 | $0.00 | 440,977 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock, par value $0.00001 per share | โ | Jul 29, 2026 | Sale | 18,217 | $33.47 | $609,635.55 | 422,760 | Direct | โ | View Details |